Connect with us

Best Practices

Marijuana Retail Report

Published

on

Marijuana Retail Report



This can happen in the “next few weeks”

Last week President Trump – told reporters What his administration considered the opportunity to transfer marijuana and will be determined within the next few weeks. It was good to hear the update on this issue because everything stopped since Trump took office in January. Of course, the cannabis industry used to work in a suspended state; But losing the momentum is difficult.

I do not predict whether the marijuana will be reorienting on the III schedule, according to HHS’s recommendations And Biden’s plan, whether we get the worst or best result. Instead, I’m going to explain how it should work. There are four basic paths:

  1. restore the process of delaying norms to accept the proposal of the last year by place marijuana in schedule III;
  2. Start a new process of development of norms, presumably with the new proposed rule;
  3. Hearing of the Novokny norms Jettison in general, and Doj simply publishes the final rule by placing marijuana on schedule III (or anywhere); or
  4. Do nothing. Say: “We like marijuana where she is, science and The contracts will be cursed

I will give some high -level thoughts about each of these paths below. However, one thing to apply to the beginning is often a re-fiction that Trump could simply re-re-decide marijuana through the executive order. He can’t. However, he could send the process, like Biden, when Biden issued an executive order 2022, sending HHS to revise marijuana control status. Essentially, Trump could say what he wanted to see, and this would probably happen, especially given the strict loyalty that DOJ showed.

Option 1: Restore Development Development process

Trump could manage Doj and Dea to restore A scary competition redevelopment of marijuana. There are several questions with this. For the first time, the application of the norms was configured from the route, to a large extent with the bad behavior of DEA. Secondly, the judge who oversees the process has retired, and Doj now holds the post that the judges of administrative law are unconstitutional. Third, this process, which is essentially a lawsuit, can pull further and further. If Trump’s administration decides what he wants marijuana somewhere except the schedule and I don’t think they will like it.

Option 2: Start a new process development process

Trump can send Doj to issue a new message proposed by placement of marijuana on III or some other schedule. Doj may claim that the previous process has been improved and/or spoiled, and lost any legitimacy veneer. This justification is likely to resist control, but I’m not sure it can be obtained from another circus involved, especially depending on the recent HHS recommendations. And again, Doj Trump is declining from administrative judges.

Option 3: No more hearings; straight to the final rule

I explained in the previous message that:

CSA “Welsh” General Prosecutor Has Powers “Schedule, Post or Deconerol” (21 USC 811 (A)). The Attorney General traditionally delegated this power to the DEA administrator (28 CFR 0.100). However, the Prosecutor General also retains the powers to plan drugs within CSA in “first instance” (28 USC 509. 510).

(Merick) Garlend had to do so. Instead – noted On the day when HHS made a recommendation to overpay. Garland’s decision is also excited Nest of the Horos of Tired Legal Arguments Around the delegation, whether Dea should be a fan here, etc.

If Trump’s administration decides to move marijuana, Doj must simply write the final rule. The marijuana can then go to the III schedule (either anywhere) within 30 or 60 days of publication. People could consider this rule confident. Considering the power of HHS, however, the clear authorized authority that stands for Doj seems like a heavy battle.

Option 4: Do nothing; marijuana stays on the schedule I

To me, this seems more likely than 1 or 2 options; and less likely than option 3. I say that with low confidence, remember you. I don’t know what’s going on behind the scenes.

If the Trump administration decides to leave marijuana where it is, then the ball returned to Congress. CSA leads to Congress the possibility of re -drug re -executives, of course, in parallel to the executive power. Congressman Greg Steb (R-FL) again filed his “Marijuana law from 1 to 3” Last weekIt will require the Prosecutor General to transfer marijuana to the III schedule within 60 days after passing. This is one potential bill.

If the Doj is not instructed to write the final rule, I would like Trump administration to demand Congress to take this and Congress to do it. As my colleague Jason AdeLston explained recently“Unlike the executive power, Congress can create a solid legal base for marijuana that protects the industry from regulation.”

As said Jake BarnesDon’t it think really?

Source: Blog Law Canna

(Tagstotranslate) Donald Trump (T) Attached (T) Federal (T) redevelopment

Best Practices

Marijuana Retail Report

Published

on

By

Marijuana Retail Report



The software aims to close operational gaps

Cannabis technology company Treez Inc. has launched early access to Winston, a new artificial intelligence platform designed to help operators of cannabis plants and other regulated retail industries manage operational tasks across multiple business systems.

Announced Wednesday, Winston is pitched as an autonomous platform for AI team partners that connects to various retail software systems and is designed to eliminate operational bottlenecks created by siled departments and disconnected technology platforms.

Winston differs from traditional AI productivity tools by integrating with systems commonly used in retail operations, including point-of-sale platforms, e-commerce software, compliance systems, payroll, human resources, accounting, loyalty programs, supply chain tools and messaging platforms, according to Treez. The company said all actions initiated by the platform go through an approval queue and include a full audit trail.

“Cannabis retail has spent a decade waiting for software to manage the operation, not just report on it,” said John Young, founder and chief executive officer of Treez. “Triz laid the groundwork for Winston’s level of operational intelligence for retail.”

Treez said the platform is already in use domestically and at SPARC, a California-based cannabis dispensary operator with seven locations in San Francisco, Sonoma County and Napa Valley.

“The launch of six dispensaries means the work of buyers, CEOs and back offices never stops,” said Robbie Rainin, SPARC’s vice president of retail operations. “Winston does the work that used to get stuck between stores and systems.”

The company also highlighted the use of the platform by Perfect Union, a California-based cannabis merchant.

“Winston is faster than any AI tool I’ve built or tested, including the ones our team put together with Codex and Claude,” said Mike Alarea, COO of Perfect Union. “Winston can answer key questions in seconds, while our homegrown version sometimes takes hours.”

Triese said Winston integrates with a variety of technology providers used throughout the cannabis retail ecosystem. Supported systems include Treez, Dutchie and Cova point of sale platforms; METRC and BioTrack compliance systems; customer relationship tools including Alpine IQ, Salesforce and HubSpot; workforce management platforms such as Deputy, ADP and Gusto; and operational tools including Distru, OnFleet and Google Workspace.

The company is opening early access to cannabis dispensary operators across the United States regardless of which point of sale system they use. Operators participating in the program will receive onboarding support directly from the Winston team.

Treez is also launching an affiliate program aimed at consultants, agencies, fractional operators and technology providers serving the retail cannabis business.

Founded in 2016, Treez provides POS, payment, e-commerce, loyalty and analytics technology to cannabis retailers in more than a dozen states. The company said it currently serves hundreds of dispensaries across the United States.

Initially focused on cannabis, Winston is positioned as an AI team partner platform for regulated industries more broadly, connecting retail operations systems and helping teams with cross-functional workflows.

Continue Reading

Best Practices

Cannabis Payments Are Facing A Reckoning As Workarounds Disappear

Published

on

By

Cannabis Payments Are Facing A Reckoning As Workarounds Disappear

For most of its legal life, the cannabis industry has relied on a number of workarounds instead of traditional payment systems such as debit and credit cards.

Operators rely on cash, cashless ATMs and weak-coded merchant accounts as approximations of what other businesses take for granted. These systems, which were not built for compliance, were built on top of rigid regulatory requirements and inadequate infrastructure.

This allowed them to disappear in one compliance review.

Industry executives and veterans already know this. Accounts using these workarounds may be closed overnight. Processors retreat without warning. Funds are frozen or delayed, and payments to wages and suppliers hang in the balance.

For years, this volatility has been accepted as part of doing business in the federal illegal market. But something is changing. Cannabis payments are starting to rise.

Are Cannabis Industry Workarounds for Payment Solutions Disappearing?

Early forms of payment for cannabis were commodities. By shutting down traditional credit and debit card processing, payment operators and providers have found ways to make transactions work even when they exceed compliance limits.

Cashless ATMs have become ubiquitous. Commercial coding workarounds filled the gap. Operators have been sifting through payment processors, aware that any solution could disappear without notice. These gimmicks kept things going, but that era is coming to an end.

Regulators and card networks increase control. Payment models that rely on gray areas are being shut down or scrutinized. What was once considered innovation is now increasingly seen as a liability with a ticking clock.

To read the rest of this article on MJ Biz Daily, Click here

Post Cannabis payments face payback as workarounds disappear first appeared on Marijuana Retail Report – News and information for cannabis retailers.

Continue Reading

Best Practices

Marijuana Retail Report

Published

on

By

Marijuana Retail Report



The DEA dispensary application portal is now live

For state-licensed medical marijuana operators, a narrow and potentially transformative window has opened that could position your business for future interstate and even global commerce.

While acting as the Prosecutor General rezoning order likely to face legal challenges, the immediate reality is that you have 60 days to act. As of yesterday, April 28, holders of state medical marijuana licenses can apply for DEA registration to manufacture (this includes cultivation and limited processing), distribute, and dispense medical marijuana.

DEA dispensary application portal is already operational and production and distribution applications are expected to comply with the standard DEA Form 225 Process.

We are not sure whether this framework would stand up to trialand if so, to what extent. However, it is clear that only those applicants who apply within this initial 60-day window are eligible for expedited review, which must take place within six months of application. The transfer order does not provide guidance on future application rounds or deadlines, leaving considerable uncertainty for those waiting.

In practical terms, this creates a first-mover advantage. If DEA registration ends up being the gateway to a federally recognized and possibly global market for medical cannabis, early applicants will have the best opportunity to participate.

We describe it as a “lottery ticket” not because it is speculative, but because it requires an upfront investment with uncertain outcomes. Retaining experienced counsel and preparing the relevant application typically costs in the range of $10,000 to $15,000 (including DEA fees), with additional costs depending on the complexity, scope and number of DEA filings required. The bet is $10,000 to $15,000 on a potential growth opportunity of hundreds of thousands or millions of dollars.

For those who are ready to move forward, we can help navigate the process effectively and strategically. Our team is one of the few with DEA ​​registration experience. We can:

  • Provide a clear overview of the DEA registration system and historical precedents
  • Prepare you for possible follow-up DEA inquiries and requests for additional information
  • Assistance in completing and submitting your application
  • Develop a comprehensive support package to strengthen your submission when the DEA seeks additional information
  • Advise on international treaty obligations and operational compliance considerations referenced by the order

If you plan to register with the DEA during this period, we encourage you to connect with our team to discuss your options. We are ready to provide you with a free consultation and help you evaluate whether this opportunity fits your business strategy.

Source: Legal Canna Blog

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media